BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4372889)

  • 1. The use of a radioimmunoassay specific for human chorionic gonadotropin in patients with molar pregnancy and gestational trophoblastic disease.
    Pastorfide GB; Goldstein DP; Kosasa TS
    Am J Obstet Gynecol; 1974 Dec; 120(8):1025-8. PubMed ID: 4372889
    [No Abstract]   [Full Text] [Related]  

  • 2. Study on the systematic use of serial estimation of human placental lactogen (hPL) and human chorionic gonadotropin (hCG) for the management of trophoblastic neoplasia.
    Chough SY
    Endocrinol Jpn; 1973 Feb; 20(1):9-21. PubMed ID: 4353253
    [No Abstract]   [Full Text] [Related]  

  • 3. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
    Khazaeli MB; Buchina ES; Pattillo RA; Soong SJ; Hatch KD
    Am J Obstet Gynecol; 1989 Feb; 160(2):444-9. PubMed ID: 2464935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin as a prognostic test for persistent trophoblastic disease in molar pregnancy.
    Khazaeli MB; Hedayat MM; Hatch KD; To AC; Soong SJ; Shingleton HM; Boots LR; LoBuglio AF
    Am J Obstet Gynecol; 1986 Aug; 155(2):320-4. PubMed ID: 3017111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The beta-subunit of chorionic gonadotrophin as a tumour marker in gestational trophoblastic disease.
    Khoo SK; Daunter B
    Aust N Z J Obstet Gynaecol; 1980 Feb; 20(1):35-42. PubMed ID: 6248013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve.
    Yedema KA; Verheijen RH; Kenemans P; Schijf CP; Borm GF; Segers MF; Thomas CM
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):787-92. PubMed ID: 7681253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trophoblastic tumor due to pregnancy. Course, prognosis and treatment].
    Bruntsch U; Gallmeier WM; Schmidt CG
    Dtsch Med Wochenschr; 1975 Feb; 100(7):313-8, 303. PubMed ID: 163725
    [No Abstract]   [Full Text] [Related]  

  • 8. Pregnancy-specific proteins as markers for gestational trophoblastic disease.
    Horne CH; Rankin R; Bremner RD
    Int J Gynecol Pathol; 1984; 3(1):27-40. PubMed ID: 6203853
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
    Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
    Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
    Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
    Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB; Lehr M; Lewis JL
    Surg Forum; 1973; 24():563-5. PubMed ID: 4377042
    [No Abstract]   [Full Text] [Related]  

  • 12. Trophoblastic disease.
    Ngan HY; Kohorn EI; Cole LA; Kurman RJ; Kim SJ; Lurain JR; Seckl MJ; Sasaki S; Soper JT
    Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 2():S130-6. PubMed ID: 22999504
    [No Abstract]   [Full Text] [Related]  

  • 13. Monitor of chemotherapy in gestational trophoblastic neoplasm by radioimmunoassay of the beta-subunit of human chorionic gonadotropin.
    Jones WB; Lewis JL; Lehr M
    Am J Obstet Gynecol; 1975 Mar; 121(5):669-73. PubMed ID: 46716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
    Duc HN; van Trommel NE; Sweep FC; Massuger LF; Thomas CM
    Int J Biol Markers; 2006; 21(1):45-9. PubMed ID: 16711513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of beta-subunit chorionic gonadotropin as an aid in diagnosis of trophoblastic disease.
    Skinner MS; Seckinger D
    Ann Clin Lab Sci; 1979; 9(4):347-52. PubMed ID: 225983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of gestational trophoblastic disease by use of actinomycin D in molar pregnancies.
    Goldstein DP
    Obstet Gynecol; 1974 Apr; 43(4):475-9. PubMed ID: 4361440
    [No Abstract]   [Full Text] [Related]  

  • 17. [Radioimmunoassay of human chorionic gonadotropin--dynamics of human chorionic gonadotropin in chorionic diseases and pregnancy].
    Kato H
    Nihon Sanka Fujinka Gakkai Zasshi; 1970 Dec; 22(12):1317-26. PubMed ID: 4321386
    [No Abstract]   [Full Text] [Related]  

  • 18. The management of patients with gestational trophoblastic neoplasia based on the antigenic properties of human chorionic gonadotropin.
    Goldstein DP; Nudemberg F; Lymeburner N; Levesque L; Shore C
    J Surg Oncol; 1973; 5(1):1-8. PubMed ID: 4736212
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
    Grinevich IuA; Tatarinov IuS; Iugrinova LG; Olefirenko GA; Dotsenko IuS
    Vopr Onkol; 1981; 27(12):19-23. PubMed ID: 6275607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gestational trophoblastic neoplasia: diagnosis with Doppler US.
    Taylor KJ; Schwartz PE; Kohorn EI
    Radiology; 1987 Nov; 165(2):445-8. PubMed ID: 2821575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.